Respiratory Diseases
Activities: NIOSH Funded Research Grants
NIOSH sponsors research and training through its extramural programs, which complement the Institute's intramural programs. More information is available from the NIOSH Office of Extramural Programs.
Report of Respiratory Disease Research Program Extramural Funding
Intramural research and extramural research both are critical to the success of RDRP at NIOSH. The following information describes extramural research funded by NIOSH during the period 1994-2006.
Web links are provided to abstracts for individual funded research projects as posted on the National Institute of Health’s Computer Retrieval of Information on Scientific Projects (CRISP) web site ( http://crisp.cit.nih.gov/). |
Extramural funding by disease category (see also Figure 1).
Total Extramural Funding 1994-2006 |
Airways Disease |
$28,891,356 |
Interstitial Disease |
$6,752,282 |
Malignancies |
$12,947,428 |
Infectious Disease |
$3,769,410 |
Nanoparticles |
$2,720,281 |
Cross-Cutting |
$32,915,281 |
|
|
Totals |
$88,023,461 |
Figure 1: Total extramural funding (research dollars) by fiscal year 1996-2006.
Airways Disease
From 1994-2006, fifty extramural projects were identified to be specific to Airways Diseases research. These Airways Diseases research projects received $28,891,356. Figure 2 shows the funding levels by year for extramural Airways Disease research.
Figure 2: Extramural funding for Airways disease research by fiscal year 1996-2006.
Interstitial Lung Disease
Extramural funding for Interstitial Lung Disease research was $6,752,282 distributed among 21 projects. Figure 3 shows the extramural funding levels of interstitial disease research (1996-2006).
Figure 3: Extramural funding for interstitial lung diseases research by fiscal year 1996-2006.
Malignancies
Extramural funding for research into occupational respiratory malignancies was $12,947,428 to support 28 projects. Figure 4 shows the historical extramural funding support for malignancy support.
Figure 4: Extramural funding for Lung Malignancy disease research by fiscal year 1996-2006.
Infectious Disease
Extramural funding of $3,769,410 supported 13 research projects related to respiratory infectious disease research. Figure 5 shows the RDRP level of extramural funding by year for all infectious disease research.
Figure 5: Extramural funding for Infectious lung disease research by fiscal year 1996-2006.
Nanoparticles
Nanoparticles are still a relatively new area of research that started receiving extramural funding in 2001. To date, $2,720,740 in extramural funds has been allocated to 7 projects involved in nanoparticle research. Figure 6 shows the extramural funding by year to support respiratory disease-related nanotechnology research.
Figure 6: Extramural funding for Nanotechnology research by fiscal year 1996-2006.
Cross-Cutting Areas
This category accounts for research projects that do not exclusively fit into only one of the five RDRP categories described as strategic goal areas. We characterized 74 projects as cross-cutting, which received total extramural funding of $32,915,281. The 74 Cross-Cutting projects were further divided into five sub-categories identified as Engineering Controls, Exposure Assessment, Respiratory Protection, Surveillance and Other (Aerosols/Exposure-Sector/Substitution). Projects related to Surveillance, 22% ($7,283,745), Exposure Assessment, 23% ($7,589,854), and Other, 44% ($14,394,955) accounted for the bulk of total Cross-Cutting funding support..
Figure 7: Extramural funding for “Cross-Cutting” research by fiscal year 1996-2006.